PerkinElmer expands fetal, maternal and neonatal health screening capability in India

PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and their environment, today announced that it has expanded its fetal, maternal and neonatal health screening capability in India, with the inauguration of the PerkinElmer Health Sciences laboratory.

“We are very excited about our partnership with PerkinElmer, because working together we can now bring the highest quality fetal and maternal health diagnostics to young Indian families all over India.”

The new laboratory, located in Chennai, will feature PerkinElmer’s advanced technologies for diagnosing common and serious health issues in expecting mothers and babies in India, including prenatal testing for Down Syndrome and other genetic disorders, maternal testing for pre-eclampsia, diabetes, thyroid disorders, and infectious disease, and newborn testing for potentially fatal inherited and metabolic disorders.

Ann-Christine Sundell, president, Genetic Screening, PerkinElmer, said, “PerkinElmer is delighted to announce the opening of our new laboratory in Chennai which brings greater availability of fetal, maternal and newborn screening to mothers and children in India. Of the more than 25 million babies born annually in India today, only a small percentage have access to medical screening to detect and treat health issues. In partnership with local leaders in fetal medicine, we look forward to improving family health outcomes.”

In support of the Company’s fetal and maternal health program, PerkinElmer is also proud to announce its collaboration with MediScan Systems, led by founder Dr. S. Suresh, a leading Fetal Medicine Specialist and sonologist in India. MediScan has recently been certified by Dr. Kypros Nicolaides, director of the Fetal Medicine Foundation UK, as the first official Fetal Medicine Foundation Training Center in India.

Dr. Suresh, director of MediScan Systems, said, “We are very excited about our partnership with PerkinElmer, because working together we can now bring the highest quality fetal and maternal health diagnostics to young Indian families all over India.”

Source:

PerkinElmer, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PerkinElmer. (2019, June 19). PerkinElmer expands fetal, maternal and neonatal health screening capability in India. News-Medical. Retrieved on August 20, 2019 from https://www.news-medical.net/news/20100218/PerkinElmer-expands-fetal-maternal-and-neonatal-health-screening-capability-in-India.aspx.

  • MLA

    PerkinElmer. "PerkinElmer expands fetal, maternal and neonatal health screening capability in India". News-Medical. 20 August 2019. <https://www.news-medical.net/news/20100218/PerkinElmer-expands-fetal-maternal-and-neonatal-health-screening-capability-in-India.aspx>.

  • Chicago

    PerkinElmer. "PerkinElmer expands fetal, maternal and neonatal health screening capability in India". News-Medical. https://www.news-medical.net/news/20100218/PerkinElmer-expands-fetal-maternal-and-neonatal-health-screening-capability-in-India.aspx. (accessed August 20, 2019).

  • Harvard

    PerkinElmer. 2019. PerkinElmer expands fetal, maternal and neonatal health screening capability in India. News-Medical, viewed 20 August 2019, https://www.news-medical.net/news/20100218/PerkinElmer-expands-fetal-maternal-and-neonatal-health-screening-capability-in-India.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
PerkinElmer launches AxION iQT gas chromatography tandem mass spectrometer